The U.S. FDA's accelerated drug approval process requires greater transparency, states the Institute for Clinical and ...
Lawmakers are clearing the way for use of the psychedelic mushroom compound psilocybin as a potential medical treatment, once ...
Good afternoon, and welcome to the Travere Therapeutics Business Update Conference Call. Today's call is being recorded. At this time, I would like to turn the conference call over to Nivi Nehra, Vice ...
Grant is an M.D./M.B.A. student at Harvard Medical School and Harvard Business School, a researcher at Boston Children’s ...
In a Phase III trial, Revolution Medicines' daraxonrasib almost doubled the survival length of people with advanced ...
Pangea Pharmaceuticals, a U.S.-based, patient-centered pharmaceutical company focused on bringing differentiated, clinically relevant products to market, today announced the U.S.
After Replimune’s advanced melanoma drug was rejected for a second time, CEO Sushil Patel slammed the FDA for failing to ...
The FDA meeting announcement follows repeated pledges by Health Secretary Robert F. Kennedy Jr. to loosen regulations on ...
The approved brand name will be publicly disclosed following EMA approval of the corresponding pharmaceutical product. This ...
The US Food and Drug Administration (FDA) is reviewing a petition to revoke the approval of Roche's top-selling drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results